The ”la Caixa” Foundation will allocate 4.6 million euros to promoting research at the Hospital Clínic Barcelona, in order to develop new, personaliz1
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients wi1
Following dietary recommendations, taking vitamin K regularly and treatment with an anticoagulant, such as Sintrom (acenocoumarol), are all important1
This discovery changes the view of the progression of leukaemia, opens the door to early diagnosis, and offers new treatment strategies.
The call for the presentation of applications for the I Estella Matutes Extraordinary Scholarship is open from September 19th to November 30th.
Despite being closely related to the digestive system, Inflammatory Bowel Disease (IBD) can affect other parts of the body such as the joints, skin a1
A study led by researchers from the Hospital Clínic-IDIBAPS shows that a new treatment without chemotherapy is effective in treating indolent clinica1
Carers from the Formació i Treball APROP job pool provide home care for people in the early stages of a bone marrow transplant. Between 2020 and 2021
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood canc1
The Spanish Agency of Medicines and Medical Devices (AEMPS) has approved CAR-T ARI-0001, developed by Hospital Clínic, as and advanced therapy drug o1
